附件4.2
A系列認股權證
認股權證股份:[_______] | 發行日期: |
本普通股認購權證(“認股權證”)保證,對於所收到的價值,_[___],而在下午5時或之前(紐約時間)[__],(“終止日期”),但此後不得認購根據開曼羣島法律成立的獲豁免公司U Power Limited(“本公司”,最多可達[______]普通股(以下可作調整,稱為“認股權證股份”)。根據本認股權證,本公司每股普通股(“普通股”)1股普通股(“普通股”)的收購價應等於第2(B)節所界定的行權價格。
定義。大寫的 本文中使用的、未另行定義的術語應具有日期為#年的特定證券購買協議(“購買 協議”)中規定的含義[___],由本公司及其簽字人簽署。
鍛鍊身體。
行使認股權證。 本認股權證所代表的購買權的全部或部分行使,可於初始行使日期或之後及終止日期當日或之前的任何時間或任何時間,以電子郵件(或電子郵件附件)提交的行使權利通知(“行使權利通知”)正式簽署的傳真副本或PDF副本交付本公司。在上述行權日期之後(I)兩(2)個交易日和(Ii)構成標準結算期的交易天數(見第 節2(D)(I)節)之前的 內,持有人應以電匯或向美國銀行開出的本票交付適用行權通知中指定的認股權證股票的總行使價,除非下文第2(C)節規定的無現金行權程序已在適用行權通知中列明。不需要任何墨水原件的行權通知,也不需要任何行權通知的任何擔保(或其他類型的擔保或公證)。 即使本協議有任何相反規定,在持有人購買了本協議項下所有可用認股權證股份並已全部行使認股權證之前,持有人不應被要求將本認股權證實際交還本公司 ,在此情況下, 持有人應在向本公司交付最終行使通知 之日起三(3)個交易日內將本認股權證交回本公司註銷。本認股權證的部分行使導致購買本協議項下可供購買的認股權證股份總數的一部分,其效果是將本協議項下可購買的已發行認股權證股份數量減少至與適用的認股權證股份購買數量相等的數額。持有人和公司應保存記錄,顯示所購買的認股權證股票數量和購買日期。公司應在收到行使通知之日起1個工作日內提交對行使通知的任何反對意見。持有人及任何受讓人接受本認股權證後,確認並同意 由於本段的規定,在購買本認股權證部分股份後,在任何給定時間可供購買的認股權證股份數目可能少於本認股權證票面所載金額。
行權價。 本認股權證項下每股普通股的行權價為美元[___][插入交易採購價格],以本協議下的 調整為準(“行使價”)。行權價格應在交易結束日(“重置日”)後第三十(30)個交易日(“重置日”)後立即重置至等於緊接重置日前二十(20)個交易日普通股在交易市場上的三個最低每股VWAP之和的算術平均值的105%的價格。
無現金行使。 如果在行使本協議的任何時候,沒有有效的登記聲明登記向持有人發行認股權證股票,或者其中包含的招股説明書無法 用於向持有人發行認股權證股票,則本認股權證也可以在該 時間通過“無現金行使”的方式全部或部分行使,即持有人有權獲得相當於通過除以 所得商數的認股權證股份的數量[(A-B)(X)](A)凡:
(A) = | 適用的:(I)在緊接適用的行使通知的日期之前的交易日的VWAP,如果該行使通知是(1)在非交易日的交易日(A)和(2)在該交易日“正常交易時間”(根據聯邦證券法頒佈的NMS法規第600(B)條的定義)開盤前的交易日,(Ii)在持有者的選擇下,(Y)適用行使通知日期前一個交易日的VWAP,或(Z)在持有人籤立適用行使通知之時主要交易市場上普通股的買入價,如行使通知是在交易日的“正常交易時間”內執行,並根據本條例第2(A)節在其後兩(2)小時內(包括至交易日“正常交易時間”結束後兩(2)小時內交付)或(Iii))在適用的行使通知的日期是交易日,且該行使通知是在該交易日的“正常交易時間”結束後,根據本協議第2(A)節的規定籤立和交付的,則為VWAP; |
(B) = | 本認股權證的行使價,按以下規定調整;以及 |
(X) = | 根據本認股權證的條款行使本認股權證時可發行的認股權證股份數目,前提是行使該認股權證的方式為現金行使而非無現金行使。 |
如果認股權證股票是以這種無現金方式發行的,雙方確認並同意,根據證券法第3(A)(9)節,認股權證股票應具有正在行使的認股權證的登記特徵。公司 同意不採取任何與第2(C)款相牴觸的立場。在不限制第2(C)節中規定的無現金行使條款、第2(D)(I)節中的違約金條款或第2(D)(Iv)節中的買入條款的情況下,不存在要求本公司以現金淨額結算本認股權證的情況。
“買入價” 指在任何日期由下列條款中的第一項確定的價格,該價格適用於:(A)如果普通股隨後在交易市場上市或報價,則為彭博新聞社報道的普通股隨後在交易市場上市或報價的當時(或最近的先前日期)交易市場上普通股的買入價(根據交易日上午9:30開始計算)。(紐約時間)至下午4:02(紐約時間)),(B)如果OTCQB或OTCQX不是交易市場,普通股在OTCQB或OTCQX(以適用者為準)該日期(或最近的前一個日期)的成交量加權平均價,(C)如果普通股沒有在OTCQB或OTCQX上市或報價,並且如果普通股的價格隨後在粉色公開市場(或 繼承其報告價格職能的類似組織或機構)報告,則如此報告的普通股的最新投標價格, 或(D)在所有其他情況下,一股普通股的公允市值由一名獨立評估師真誠地選擇,由當時尚未償還併為本公司合理接受的多數證券的購買者 選定,費用和支出應由本公司支付。
“VWAP” 指於任何日期由下列第一項適用的價格決定的價格:(A)如普通股當時在交易市場上市或報價,則指彭博資訊(Bloomberg L.P.)自上午9:30起的交易日(根據交易日 起)普通股在該日期(或最近的前一個日期)的每日成交量加權平均價。(紐約市時間)至下午4:02(紐約時間)),(B)如果OTCQB或OTCQX不是交易市場,則為適用的OTCQB或OTCQX在該日期(或最近的前一日期)普通股的加權平均價,(C)如果普通股當時沒有在OTCQB或OTCQX上市或報價,並且如果普通股的價格隨後在粉色公開市場(或繼承其報告價格職能的類似組織或機構)上報告,則如此報告的普通股的最新出價 ,或(D)在所有其他情況下一股普通股的公允市值,由持有該證券多數權益的購買者真誠選擇的獨立評估師確定,該股票當時尚未發行且合理地被本公司接受,其費用和開支由本公司支付。
2
儘管本協議有任何相反規定 ,在終止日,本認股權證應根據第 2(C)節通過無現金行使方式自動行使。
鍛鍊的機械學。
行使時交付認股權證 股票。如果公司當時是託管系統(“DWAC”)的參與者,並且 (A)有一份有效的登記聲明允許 持有人向 持有人發行或轉售認股權證股票,則公司應安排轉讓代理將根據本協議購買的認股權證股票通過 持有人在託管信託公司的存款或提款的餘額賬户記入賬户,從而將根據本協議購買的認股權證股份轉給 持有人,或(B)認股權證是通過無現金行使行使的。或以其他方式將持有人或其指定人的姓名登記在本公司股東名冊內,作為持有人根據該行使而有權獲得的認股權證股份數目的持有人 行使並將有關該等認股權證股份的證書實物交付至持有人在行使認股權證通知中指定的地址 ,日期為(I)行權通知送交本公司後兩(2)個交易日中最早的日期,(br}(Ii)向本公司交付行使權總價後的一(1)個交易日,及(Iii)由向本公司交付行使權通知後的標準結算期組成的交易日的數目(該日期,即“認股權證股份交付日期”);在交付行使通知後,就SHO規則而言,持有人應被視為已行使本認股權證的認股權證股份的記錄持有人,而不論認股權證股份的交付日期 ,但前提是在(I)兩(2)個交易日及(Ii)組成標準結算期的交易日內收到行使總價(無現金行使除外)的付款 ,以較早者為準。如公司因任何原因未能向持有人交付認股權證股份,但須於認股權證股份交割日期發出行使通知,則公司應就行使認股權證股份每1,000美元向持有人支付現金,作為違約金,而非罰款(以適用行使認股權證通知日期普通股的VWAP為基準)。於該認股權證股份交割日後的每個交易日每交易日10美元(在該等算定損害賠償開始產生後的第三個交易日增加至每個交易日20美元),直至該認股權證股份交付或持有人 撤銷該等行使為止。公司同意保留一名參與FAST計劃的轉讓代理,只要本認股權證 仍未履行並可行使。本文所用的“標準結算期”指在行使通知交付之日在本公司一級交易市場上與普通股有關的標準結算期 ,以若干交易日為單位。
行使時交付新的 認股權證。如本認股權證已部分行使,本公司應應持有人的要求及在認股權證股份交付時交回本認股權證證書,向持有人交付一份新的認股權證,證明持有人有權購買本認股權證所要求的未購買認股權證股份,而新認股權證在所有其他方面應與本認股權證完全相同。
撤銷權。 如果本公司未能促使轉讓代理在認股權證股份交割日之前根據第2(D)(I)條將認股權證股份轉讓給持有人 ,則持有人將有權撤銷該項行使。
3
未能在行使時及時交付認股權證股票的買入補償 。除持有人可享有的任何其他權利外,如果本公司未能促使轉讓代理根據上文第(Br)2(D)(I)節的規定在認股權證股份交割日或之前行使認股權證股份,並且在該日期之後,持有人被其 經紀人要求購買(在公開市場交易或其他情況下)或持有人的經紀公司以其他方式購買,為滿足持有人出售認股權證股份而交付的普通股 ,公司應(A)以現金形式向持有人支付(如有)(X)持有人的總收購價(包括經紀佣金、如此購買的普通股)超過(Y)的金額乘以(1)本公司須在 發行時間向持有人交付的與行權有關的認股權證股份數目,(2)執行導致該購買義務的賣單的價格,以及(B)在持有人的選擇下, 恢復認股權證未獲履行的部分及同等數目的認股權證股份(在此情況下,該項行使應被視為撤銷),或向持有人交付假若 公司及時履行其行使及交付義務將會發行的普通股數目。例如,如果持有人購買總購買價為11,000美元的普通股,以支付與試圖行使普通股有關的買入,而總銷售價 導致該購買義務為10,000美元,則根據上一句(A)款,本公司應向持有人支付1,000美元。持有人應向公司提供書面通知,説明就買入而應向持有人支付的金額,並應公司的要求提供此類損失金額的證據。本協議並不限制持有人根據本協議在法律或衡平法上可尋求任何其他補救措施的權利,包括但不限於特定履行判令及/或有關本公司未能按本協議條款所要求在行使認股權證時及時交付普通股的強制令豁免。
沒有分數 股票或Scrip。本認股權證行使時,不得發行代表零碎股份的零碎股份或代表零碎股份的股票。如 股份持有人於行使該權力時有權購買任何零碎股份,本公司將於其選擇時就該最後零碎股份支付現金調整,金額為該零碎股份乘以行使價,或 向上舍入至下一個完整股份。
手續費、税金和費用。發行認股權證股票應免費向持有人收取與發行該等認股權證股份有關的任何發行或轉讓税或其他附帶費用,所有税項及開支均由本公司支付,而該等認股權證股份應以持有人的名義或按持有人指示的名稱發行;然而, 如認股權證股份以持有人以外的名義發行,則本認股權證於交回行使時,須附同由持有人正式簽署的轉讓表格,而本公司可要求支付一筆足以償還其附帶的任何轉讓税的款項,作為條件。本公司應支付當日處理任何行使通知所需的所有轉讓代理費用,以及當日以電子方式交付認股權證股份所需的所有費用予存託信託公司(或履行類似職能的另一間已成立結算公司)。
賬簿關閉。 根據本協議的條款,公司不會以任何妨礙及時行使本認股權證的方式關閉其股東賬簿或記錄。
4
霍爾德的 鍛鍊限制。本公司不得行使本認股權證,持有人亦無權根據第2條或其他規定行使本認股權證的任何部分,惟在適用行使通知所載於行使後的發行生效後,持有人(連同持有人的聯營公司,以及與持有人或持有人的任何聯屬公司作為一個集團行事的任何其他人士(該等人士,“出讓方”))將 實益擁有超出實益擁有權限額(定義見下文)的權利。就前述句子而言,持有人及其聯營公司及出資方實益擁有的普通股股數應包括因行使本認股權證而可發行的普通股數量,但不包括因(I)行使持股權證或其任何關聯公司或出讓方實益擁有的剩餘未行使部分及(Ii)行使或轉換本公司任何其他證券(包括但不限於,任何其他普通股等價物),但須受有關轉換或行使限制的限制 ,類似於本協議所載由持有人或其任何聯營公司或授權方實益擁有的限制 。除上一句所述外,就本第2(E)條而言,實益所有權應根據《交易所法案》第13(D)節及據此頒佈的規則和條例計算, 持有人確認本公司並未向持有人表示該計算符合《交易所法案》第13(D)條的規定 ,並由持有人獨自負責根據該條款提交的任何時間表。在第2(E)款中包含的限制適用的範圍內,確定本認股權證是否可行使(與持有人與任何關聯方和出資方共同擁有的其他證券有關)以及本認股權證的哪一部分可行使,應由持有人自行決定,提交行使通知應視為持有人決定是否可行使本認股權證(與持有人與任何關聯方和出資方共同擁有的其他證券有關) 以及本認股權證的哪部分可行使。在每種情況下,本公司均受實益所有權限制,且本公司無義務核實或確認該等決定的準確性。此外,上述關於任何集團地位的決定應根據《交易所法案》第13(D)節及其頒佈的規則和條例來確定。就本第2(E)條而言,在釐定已發行普通股數目時,持有人可依據(A)本公司向監察委員會提交的最新定期或年度報告(視屬何情況而定)、(B)本公司較新的公告或(C)本公司或轉讓代理較新發出的書面通知所反映的已發行普通股數量。如持有人提出書面或口頭要求,本公司須於一(1) 個交易日內以口頭及書面方式向持有人確認當時已發行的普通股數目。在任何情況下,普通股已發行股份的數目 應由持有人或其聯營公司或歸屬方自報告該等已發行普通股數目 之日起,於轉換或行使本公司證券(包括本認股權證)後釐定。“實益擁有權限額”應為在行使本認股權證可發行普通股生效後立即發行的普通股數量的4.99% 。持有人在通知本公司後,可增加或減少本第2(E)節的實益所有權限制條文,但實益擁有權限制 在任何情況下不得超過緊隨持有人行使本認股權證而發行普通股後已發行普通股數目的9.99%,而本第2(E)節的規定將繼續適用。 受益所有權限制的任何增加都不會生效,直到ST 本段規定的解釋和實施方式不應嚴格遵守第2(E)節的條款,以糾正本段(或其任何部分)可能存在缺陷或與本文所載的預期受益所有權限制不一致的情況,或作出必要或可取的更改或補充以適當地實施此類限制。 本段包含的限制應適用於本認股權證的後續持有人。
5
做了一些調整。
分紅 和拆分。如果本公司在本認股權證尚未發行期間的任何時間:(I)派發股息或以其他方式對其普通股或任何其他股本或股本等值證券進行分派(為免生疑問,不包括本公司在行使本認股權證時發行的任何普通股),(Ii)將其已發行的 普通股細分為更多數量的股份,(Iii)將其已發行普通股 合併(包括以反向分拆的方式)為較少數目的股份或(Iv)透過將其普通股重新分類而發行本公司的任何股本,則在每一種情況下,行使價須乘以一個分數,分子為緊接該事件發生前已發行的普通股(不包括庫存股,如有的話)的股份數目,而分母為緊接該事件發生後已發行的普通股數目。在行使本認股權證時可發行的股份數目應按比例調整 ,以使本認股權證的總行使價格保持不變。根據本第3(A)條作出的任何調整應在確定有權收取該等股息或分派的股東的登記日期後 立即生效 ,如屬分拆、合併或重新分類,則應於生效日期後立即生效。
管轄權。 有關本保證書的解釋、有效性、執行和解釋的所有問題均應根據《購買協議》的規定作出決定。
限制。 持有人承認,在行使本認股權證時獲得的認股權證股票,如果未登記且持有人未使用無現金行使,則在轉售時將受到州和聯邦證券法的限制。
非豁免和 費用。持有人的任何交易過程或任何延誤或未能行使本協議項下的任何權利,均不得視為放棄該等權利或以其他方式損害持有人的權利、權力或補救。在不限制本認股權證或購買協議的任何其他條款的情況下,如果本公司故意及明知不遵守本認股權證的任何條款,導致持有人遭受任何重大損害,本公司應向持有人支付足以支付持有人因收取根據本協議或以其他方式執行本協議項下的任何權利、權力或補救措施而產生的 任何款項而產生的任何費用和開支,包括但不限於合理的律師費,包括上訴訴訟費用。
6
通知。 本公司要求或允許向持有人發出或交付的任何通知、請求或其他文件應按照購買協議的通知條款 交付。
7
責任限制 。如持有人並無採取任何肯定行動以行使本認股權證以購買認股權證 股份,亦無列舉持有人的權利或特權,則本協議任何條文均不會導致持有人就購買任何普通股的價格或作為本公司股東而承擔任何責任,不論該等責任是由本公司或本公司的債權人主張的。
補救措施。 持有人除了有權行使法律授予的所有權利,包括追討損害賠償外,還有權具體 履行其在本認股權證項下的權利。本公司同意,金錢賠償不足以補償因其違反本認股權證規定而蒙受的任何損失,因此,本公司同意放棄且不在任何針對具體履約的訴訟中提出法律補救即已足夠的抗辯理由。
繼任者和 分配。在適用證券法的規限下,本認股權證及本認股權證所證明的權利及義務,對本公司的繼承人及獲準受讓人及持有人的繼承人及獲準受讓人的利益具有約束力。本認股權證的 條款旨在使本認股權證的任何持有人不時受益,並可由認股權證持有人或認股權證股份持有人執行。
經本公司及持有人書面同意,本認股權證可予修改或修訂,或放棄本認股權證的規定。
8
可分割性。 在可能的情況下,本保證書的每一條款均應解釋為在適用法律下有效和有效,但如果本保證書的任何條款被適用法律禁止或無效,則該條款在該禁止或無效的範圍內無效,但不會使該等條款的其餘部分或本保證書的其餘條款無效。
Transferability. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary and subject to Sections 2(a) and 2(d)(ii), the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.
9
Miscellaneous.
No Rights as Shareholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.
Authorized Shares.
The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Ordinary Shares a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of completing the issuance of the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Ordinary Shares may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and non-assessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its amended and restated memorandum and articles of association or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.
10
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.
Non-waiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Ordinary Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or a holder of Warrant Shares.
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.
********************
(Signature Page Follows)